Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India
- PMID: 24614165
- PMCID: PMC3948746
- DOI: 10.1371/journal.pone.0091028
Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India
Abstract
Introduction: Adverse drug reactions related to antiretroviral therapy (ART) remain a challenge in resource-limited settings, often causing significant morbidity and impaired adherence leading to treatment failure. This 2-year prospective study aimed to describe patterns and predictors of adverse reactions to first-line ART and assess the impact of these events on treatment success.
Methods: Between 2010-2013, 321 ART-naïve eligible adults were enrolled at two clinics in southern India. ART regimens included zidovudine or stavudine plus lamivudine, plus nevirapine or efavirenz. Pill count adherence, immunological and virological monitoring, and laboratory-based adverse drug reactions were measured prospectively and analyzed.
Results: Among 321 patients in the study, 289 (90.0%) patients experienced at least 1 adverse reaction, and 85 (26.5%) experienced at least 1 severe reaction. The incidence rate was 52 and 15 per 100 person-years for all reactions and severe reactions respectively. The cumulative incidence of zidovudine-induced anemia was 37.1% over 2 years. At 12 and 24 months, the proportion of patients with optimal adherence, undetectable viral load and CD4 counts >350 cells/mm3 were similar between patients who experienced or did not experience severe adverse drug reactions.
Conclusions: Our results highlight the high frequency of ART-related adverse drug reactions among individuals initiating first-line ART in India, underscoring the importance of detailed counseling and monitoring for maintaining ART durability. Severe drug-induced anemia needs to be addressed urgently with alternative first-line agents, and close laboratory surveillance. High treatment efficacy despite decreased drug safety seen here may be because patients have limited treatment options. Our results support the use of currently recommended safer first-line ART regimens that minimize the risk of severe life-threatening toxicities and provide for a better quality of life.
Trial registration: ISRTCN Registry: ISRCTN79261738.
Conflict of interest statement
Figures

Similar articles
-
Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.Curr HIV Res. 2016;14(1):71-9. doi: 10.2174/1570162x13666150825123750. Curr HIV Res. 2016. PMID: 26303008
-
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.AIDS Res Hum Retroviruses. 2008 Mar;24(3):393-9. doi: 10.1089/aid.2007.0219. AIDS Res Hum Retroviruses. 2008. PMID: 18327976 Clinical Trial.
-
Adverse effects after HAART Initiation in resource-limited settings: a prospective study from Mysore, India.J Infect Dev Ctries. 2010 Nov 24;4(11):750-3. doi: 10.3855/jidc.934. J Infect Dev Ctries. 2010. PMID: 21252454
-
API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.J Assoc Physicians India. 2006 Jan;54:57-74. J Assoc Physicians India. 2006. PMID: 16649742 Review.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
Cited by
-
Evaluation of Adverse Drug Reaction Profile of Drugs Used as First-Line Antiretroviral Therapy.Interdiscip Perspect Infect Dis. 2018 Aug 2;2018:8095609. doi: 10.1155/2018/8095609. eCollection 2018. Interdiscip Perspect Infect Dis. 2018. PMID: 30174689 Free PMC article.
-
Joint modeling of predictors of adverse drug reactions and viral load changes over time among adult patients on ART at Nigist Eleni Mohammed Memorial comprehensive specialized hospital, central Ethiopia.BMC Infect Dis. 2025 Jul 12;25(1):915. doi: 10.1186/s12879-025-11294-7. BMC Infect Dis. 2025. PMID: 40652201 Free PMC article.
-
Iatrogenesis: A review on nature, extent, and distribution of healthcare hazards.J Family Med Prim Care. 2018 Mar-Apr;7(2):309-314. doi: 10.4103/jfmpc.jfmpc_329_17. J Family Med Prim Care. 2018. PMID: 30090769 Free PMC article. Review.
-
The burden of anemia among Chinese HIV-infected patients following the initiation of antiretroviral therapy in the treat-all era: a nationwide cohort study.BMC Infect Dis. 2023 Oct 19;23(1):704. doi: 10.1186/s12879-023-08675-1. BMC Infect Dis. 2023. PMID: 37858044 Free PMC article.
-
Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy.BMC Infect Dis. 2020 Feb 19;20(1):158. doi: 10.1186/s12879-020-4878-2. BMC Infect Dis. 2020. PMID: 32075584 Free PMC article.
References
-
- Murphy RA, Sunpath H, Kuritzkes DR, Venter F, Gandhi RT (2007) Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. J Infect Dis 196 Suppl 3S449–456. - PubMed
-
- Max B, Sherer R (2000) Management of the adverse effects of antiretroviral therapy and medication adherence. Clinical Infectious Diseases 30 Suppl 2S96–116. - PubMed
-
- O’Brien ME, Clark RA, Besch CL, Myers L, Kissinger P (2003) Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr 34: 407–414. - PubMed
-
- Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, et al. (2010) Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients. HIV Med 11: 104–113. - PubMed
-
- National AIDS Control Organisation Annual Report, 2012–2013. Department of AIDS Control. Ministry of Health and Family Welfare, New Delhi. Available: http://www.naco.gov.in/NACO/Quick_Links/Publication/Annual_Report/NACO_A.... Accessed 20 Jan 2014.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials